Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. (TAI: 1795) is trading at NT$179.00, about ₹540 at today's TWD/INR rate, as of 30 Sep 2026, 1:30 AM ET, up 0.85% today. Lotus Pharmaceutical is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.
Quote
Today's low
NT$177.50
Today's high
NT$179.50
52 week low
NT$168.31
52 week high
NT$369.50
1795 opened at NT$178.00, closed previously at NT$177.50, and has traded between NT$168.31 and NT$369.50 over the past 52 weeks.
About
Lotus Pharmaceutical Co., Ltd. operates as a pharmaceutical enterprise, specializing in the research, development, production, and sale of generic medicines. Its market presence extends across Taiwan, South Korea, the United States, and other global territories. The company primarily targets therapeutic areas such as oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system conditions with its generic product line. In addition to prescription generics, Lotus also offers a diverse array of over-the-counter drugs. Diversifying its business activities, the firm engages in the wholesale distribution of cosmetics, the retail of specialized clinical equipment, and provides biotechnology consulting. It also handles the sale of pharmaceuticals and medicinal chemicals, conducts marketing campaigns, offers market planning and business intelligence services, and provides advisory on health management and health technology. Furthermore, Lotus delivers a suite of services including project management for pharmaceutical regulatory compliance, data collection, and agency functions. It also operates as a healthcare consultancy and a Contract Research Organization (CRO). Established in 1966, Lotus Pharmaceutical Co., Ltd. maintains its principal office in Taipei City, Taiwan. The company is a subsidiary of Alvogen Emerging Markets Holdings Limited.
Key statistics
Avg. volume
1.58M
Market cap
NT$47.04B
P/E Ratio
12.39
Price-to-sales ratio
1.65
Enterprise value
NT$121.85B
Free cash flow yield
4.25%
Debt-to-equity ratio
2.40
Return on equity
19.85%
ROIC
5.20%
Beta
0.38
Dividend yield
1.43%
Last dividend
NT$2.57
Financial overview
Revenue
NT$20.51B
Earnings per share
NT$18.14
Free cash flow
NT$3.13B
Net profit margin
13.22%
Gross margin
45.75%
EBITDA
NT$7.44B
Revenue growth
10.36%
Similar securities
This is not an investment recommendation
Lotus Pharmaceutical for Indian investors
Lotus Pharmaceutical is listed on the Taiwan Stock Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.
Taxes on Lotus Pharmaceutical for Indian residents
Trading and limits
- Trading hours
- 9:00 am – 1:30 pm SGT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Lotus Pharmaceutical’s current yield is 1.43%.Dividend tax explained
FAQs
Can I buy Lotus Pharmaceutical on Paasa?
Lotus Pharmaceutical (1795) has been listed on the Taiwan Stock Exchange since 2007, in the Drug Manufacturers - Specialty & Generic industry. Lotus Pharmaceutical is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.
How much does one Lotus Pharmaceutical share cost in rupees?
One Lotus Pharmaceutical share is NT$179.00 — about ₹540 at a TWD/INR rate of 3.02 on 29 Sep 2026. Both the Lotus Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for investing abroad from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.
How are gains on Lotus Pharmaceutical shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the TWD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Lotus Pharmaceutical price.
Does Lotus Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. Lotus Pharmaceutical pays a dividend and the current yield is 1.43%; the last declared dividend was NT$2.57 per share, about ₹7.74. Dividends are taxed at your slab rate in India.
When does TAI trade, in Indian time?
The Taiwan Stock Exchange trades 6:30 am – 11:00 am IST in Indian time.
Do I have to declare Lotus Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.
Does the rupee rate affect what I make on Lotus Pharmaceutical?
Yes. Lotus Pharmaceutical is priced in TWD, so your rupee outcome combines the TWD move with the TWD/INR move between the day you remit and the day you convert back.